Why you stop losing weight on a GLP-1: plateaus explained

It is the single most-asked question in every GLP-1 community: the scale stopped moving — is the medicine still working, or did I break it? The honest, reassuring answer is that a plateau is the expected ending of the weight-loss curve, not a sign that anything has failed. This page explains why loss slows, what the trials show about when it tends to happen, and where the line sits between “normal” and “worth a conversation.”

It describes; it does not prescribe. It contains no doses, no titration numbers, and nothing about changing how you take a medicine — those belong to the person who knows your history.

Why does weight loss slow down and stop on a GLP-1?

Because your body defends a new, lower set point — and the medicine was never going to override that physiology forever. Weight loss is not a straight line down. As you lose weight, several well-documented systems push back at once.

The clearest is metabolic adaptation. When you lose weight, your resting metabolic rate falls — and it falls more than the smaller body alone would predict. A weight-reduced body becomes more energy-efficient, burning fewer calories at rest and during movement than it did before (Ravussin and colleagues). At the same time, hunger-side hormones shift: appetite-suppressing leptin drops while hunger signals rise. A GLP-1 medicine works with appetite, but it does not switch off this underlying biology.

The result is an energy balance that drifts back toward equilibrium. Early on, the appetite effect creates a large gap between intake and expenditure, and weight comes off quickly. Over months, expenditure falls and the body adapts until intake and output re-balance at a new, lower weight. That re-balancing is the plateau. Reaching it means the drug did its job and your body found a new steady state — not that the drug “stopped working.”

When does the plateau usually happen?

The trials give real numbers — and they differ by medicine and by starting body size.

Medicine (trial)	Typical time the curve flattens	What the data show
Tirzepatide (SURMOUNT-1 analysis)	~24–36 weeks	Median time to plateau ranged from about 24 weeks in those with the least excess weight to about 36 weeks in those with the most; by 72 weeks, roughly 88–90% had reached a plateau.
Semaglutide (STEP 1, 68-week trial)	near end of treatment	In the continuous 68-week trial, weight loss kept going for over a year and was levelling off near the end of treatment.

Two takeaways. First, the heavier you start, the later you tend to plateau — there is simply more curve to travel. Second, flattening is normal and universal: in the tirzepatide analysis, nearly everyone reached a plateau by the trial’s end, and they had still lost a great deal of weight. A plateau is where the trial participants ended up too.

Is a plateau the same as the medicine “not working”?

No — and the STEP 4 trial draws the distinction cleanly. People who reached their plateau and kept taking semaglutide held onto their loss; those switched to placebo gradually regained weight. The medicine’s ongoing job at a plateau is less about driving the number down and more about holding the line against the biology that wants to push it back up. A stable weight on treatment is the medicine working, not failing.

This is the heart of “is it still working?”: people judge success by continued loss, when after several months the realistic measure becomes successful defence of the weight already lost.

Normal plateau vs. worth a clinician chat

• Normal: the scale stalls after several months of steady loss; weight holds or drifts within a few pounds week to week; appetite and “food noise” are still well-controlled; you feel well.
• Worth a conversation: you plateaued very early and far from any reasonable goal; appetite and cravings have clearly come back; the scale is trending up over weeks, not just flat; or you reached your goal and want a plan for what maintenance looks like.

A plateau on its own is not a problem to “fix.” A plateau with returning hunger, or steady regain, is a reason to talk it through — not a reason to change anything on your own.

Frequently asked questions

Did I plateau because I did something wrong? Almost certainly not. Plateaus happen to nearly everyone in the trials and reflect normal physiology — falling resting metabolism and shifting appetite hormones — plus the natural fact that a smaller body burns fewer calories. StatPearls notes the large majority of people lose-then-plateau.

Will I lose more if I just wait? Sometimes the curve has more to give and patience is enough; often the plateau is the body’s new steady state. The trials show most people settle at a plateau and stay near it. What happens next for you is an individual question for your clinician — not a number this page can predict.

Does plateauing mean I should change my dose? That is not a question to answer from a website. Anything about how a medicine is taken is a clinician decision based on your full picture. This page deliberately gives no dosing guidance.

If I stop now that I’ve plateaued, will the weight stay off? The maintenance evidence points the other way: in STEP 4, stopping led to gradual regain. Reaching a stable weight is the start of the maintenance conversation, not the end of it.

Questions to ask a clinician

• Is my plateau where you’d expect for how long I’ve been treated and where I started?
• Has my appetite or food-noise changed — and does that change the plan?
• What does “success” look like from here: more loss, or holding what I’ve lost?
• What’s our maintenance plan — continue, adjust, or transition — and what are the criteria for each?
• Should we look at body composition or other markers, not just the scale number?

Red flags / when to seek care

A plateau itself is not a medical emergency. These are separate symptoms that warrant prompt clinical contact regardless of the scale:

• Steady, unexplained weight regain on treatment alongside clearly returning hunger — worth reviewing the plan, not ignoring.
• Severe or persistent abdominal pain, especially radiating to the back with vomiting — seek care; this is not a plateau symptom.
• Signs of dehydration or inability to keep fluids down from ongoing GI symptoms.
• New, severe, or frightening symptoms of any kind — these are reasons to call, not data points to grade.

A stalled scale asks for perspective. The symptoms above ask for a clinician. Knowing which is which is most of the skill.